William Olson

Senior Vice President, Therapeutic Proteins · Regeneron Pharmaceuticals

Biopharmaceuticals

William Olson is senior vice president of therapeutic proteins at Regeneron Pharmaceuticals. He joined as a vice president in 2013 after nineteen years at Progenics Pharmaceuticals and earlier scientific work at MicroGeneSys and Johnson & Johnson.

Last reviewed: Oct 21, 2026

William Olson

Senior Vice President, Therapeutic Proteins Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

William Olson is senior vice president of therapeutic proteins at Regeneron Pharmaceuticals. He joined as a vice president in 2013 after nineteen years at Progenics Pharmaceuticals and earlier scientific work at MicroGeneSys and Johnson & Johnson.

Career Highlights

  • Joined Regeneron as a vice president in 2013.
  • Leads therapeutic proteins, including antibody generation for drug discovery.
  • Previously spent nineteen years at Progenics Pharmaceuticals.

Professional Journey

Olson worked as a scientist at MicroGeneSys and Johnson & Johnson’s R.W. Johnson Pharmaceutical Research Institute. He subsequently spent nineteen years at Progenics Pharmaceuticals.

He joined Regeneron in 2013 as a vice president and now serves as senior vice president of Therapeutic Proteins. His responsibilities include antibody generation using research technologies, a component of the company’s drug discovery activities.

His background combines chemical engineering and biochemical engineering training with scientific work across several biotechnology and pharmaceutical organizations. That experience preceded his leadership of the therapeutic proteins function at Regeneron.

Education

Olson earned a BS in chemical engineering from the University of North Dakota and a PhD in biochemical engineering from the Massachusetts Institute of Technology.